Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073281 · ClinicalTrials.gov registry record · Phase 1
Islet Transplantation for Patients With Type 1 Diabetes
A Phase 1 study of Diabetes Mellitus, Type 1, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00073281: Completed Phase 1 study of Diabetes Mellitus, Type 1, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00073281 is a Phase 1 study of Diabetes Mellitus, Type 1 that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 10 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00073281, a Phase 1 study of Diabetes Mellitus, Type 1, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This protocol will test whether Type 1 diabetes (T1DM) can be reversed in patients with stable renal allografts by islet transplantation.
Conditions Studied
Interventions
- PROCEDURE Islet transplantation
Study Locations (1)
New York
- Columbia Presbyterian Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-12 |
| Phase | Phase 1 |
What the finished NCT00073281 record still lists
NCT00073281 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 1 intervention - of which Islet transplantation is the first listed.
NCT00073281 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT00073281 about?
NCT00073281 is a clinical study titled "Islet Transplantation for Patients With Type 1 Diabetes". This protocol will test whether Type 1 diabetes (T1DM) can be reversed in patients with stable renal allografts by islet transplantation.
What is the current status of trial NCT00073281?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2003-08. Estimated completion is 2004-12.
What conditions does trial NCT00073281 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1.
What interventions are being tested in trial NCT00073281?
The interventions under investigation include: Islet transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT00073281?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00073281 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00073281's enrollment target sits among peer trials
10 111th of 118 higher than 5 of 118 other Diabetes Mellitus, Type 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes
RECRUITING · Phase 1
-
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
RECRUITING · Phase 1
-
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
RECRUITING · Phase 1
-
Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes
RECRUITING · Phase 1
-
Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells
RECRUITING · Phase 1
-
Allogenic Islet Cell Transplantation
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
- NCT01870752 · 10 participants · NA
Ovarian Tissue Transplantation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia